Rchr
J-GLOBAL ID:201501083978543942
Update date: Mar. 24, 2024
Takada Kohichi
タカダ コウイチ | Takada Kohichi
Affiliation and department:
Homepage URL (1):
https://kaken.nii.ac.jp/d/r/90398321.ja.html
Research field (3):
Tumor diagnostics and therapeutics
, Gastroenterology
, Hematology and oncology
Research keywords (12):
がんゲノム医療
, がん免疫療法
, Medical Oncologist
, ROS
, Wntシグナル
, BCL9
, 肝細胞癌
, 新規大腸癌治療法開発
, 癌細胞における鉄代謝
, Multiple myeloma
, 細胞標的治療
, NASH
Research theme for competitive and other funds (16):
- 2023 - 2026 プロテオーム解析による骨肉腫の肺転移機序解明と新規治療開発
- 2022 - 2025 Development a novel therapy applying immunogenic cell death for AYA patients with refractory soft tissue sarcoma
- 2022 - 2025 Development a novel immunotherapy for HCC targeted by BRG1
- 2021 - 2024 MAGE-A4抗原を発現する切除不能進行・再発腫瘍に対するCAR-T細胞療法の医師主導第I相治験
- 2020 - 2023 ショットガンプロテオミクスを用いた神経線維腫の悪性化機序解明と治療への応用
- 2019 - 2022 Development of a new targeted anticancer treatment for Adolescent and Young Adult refractory soft tissue sarcoma
- 2019 - 2022 Development a novel therapy for hepatocellular carcinoma by targeting STEAP1
- 2017 - 2020 Development of a new treatment for colorectal cancer using the glucose metabolism characteristics.
- 2016 - 2019 Reactive oxygen species play roles in multiple myeloma pathogenesis
- 2015 - 2018 The effect of exosomal miRNA on AML/MDS stromal cells
- 2013 - 2016 Identifing novel therapeutic target molecules in multiple myeloma using BCL9-ChIPSeq
- 2011 - 2012 Targeted disruption of the BCL9/beta-catenin complex in colorectal cancer using stapled peptide
- 2008 - 2010 A novel anti-fibrotic therapy for scirrhous gastric cancer.
- 2008 - 2009 癌随伴線維芽細胞を標的としたがん治療法の開発
- 2007 - 2008 非アルコール性脂肪性肝炎発症に関わる鉄代謝異常の分子機構解析と治療法の開発
- 2006 - 2007 TGF-βシグナルにお1るプロテインボスフターゼ2Aの癌抑制潰伝子としての意義
Show all
Papers (214):
-
Kazuhiro Ogi, Takahiro Iwamoto, Takashi Sasaya, Koyo Nishiyama, Takaaki Tokura, Takanori Sasaki, Hironari Dehari, Yohei Arihara, Kazuyuki Murase, Masato Saito, et al. Notch signaling genes and CD8+ T-cell dynamics: Their contribution to immune-checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study. Cancer medicine. 2024. 13. 5. e6985
-
Joji Muramatsu, Yohei Arihara, Makoto Yoshida, Tomohiro Kubo, Hajime Nakamura, Kazuma Ishikawa, Hiromi Fujita, Shintaro Sugita, Takumi Konno, Takashi Kojima, et al. Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer. Cancer Science. 2024
-
佐藤 昌則, 大沼 啓之, 早坂 尚貴, 濱口 孝太, 村瀬 和幸, 高田 弘一, 宮西 浩嗣, 加藤 淳二, 染谷 正則, 坂田 耕一. Stage IVa進行食道癌におけるDocetaxel/CDGP/5-FU・放射線同時併用療法(DNF-R)の予後解析. 北海道医学雑誌. 2023. 98. 2. 139-139
-
Michihiro Ono, Shutaro Oiwa, Atsushi Uesugi, Seiya Saito, Ryota Yokoyama, Makoto Usami, Tomoyuki Abe, Miri Fujita, Kohichi Takada, Masahiro Maeda. Tissue acquisition for comprehensive genomic profiling of gallbladder cancer using a forward-viewing echoendoscope in a patient who underwent Roux-en-Y reconstruction. Clinical journal of gastroenterology. 2023
-
Akira Kawai, Mikiya Ishihara, Tomoki Nakamura, Shigehisa Kitano, Shintaro Iwata, Kohichi Takada, Makoto Emori, Koji Kato, Makoto Endo, Yoshihiro Matsumoto, et al. Safety and Efficacy of NY-ESO-1 Antigen-specific T-cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023
more...
MISC (89):
-
大沼 啓之, 小野山 直輝, 濱口 孝太, 早坂 尚貴, 佐藤 昌則, 村瀬 和幸, 高田 弘一, 宮西 浩嗣, 村上 武志, 伊東 竜哉, et al. 食道癌 診断と治療のup to date 食道腺癌を含めて 切除可能進行食道癌に対する三剤併用療法ベースの化学放射線療法は手術療法を代替できるか?:傾向スコアマッチング分析. 日本消化器病学会北海道支部例会・日本消化器内視鏡学会北海道支部例会プログラム・抄録集. 2021. 128回・122回. 35-35
-
荻和弘, 小林淳一, 小林淳一, 西山廣陽, 小池和茂, 高田弘一, 染谷正則, 宮崎晃亘. 再発または遠隔転移を有する口腔癌に対しニボルマブ投与は遺伝子変異が指標となるか. 日本癌治療学会学術集会(Web). 2020. 58th
-
松野 鉄平, 村瀬 和幸, 高田 弘一, 河野 豊, 平川 昌宏, 宮西 浩嗣, 小船 雅義, 加藤 淳二. 低用量IL2はBCL2の発現を誘導することでCD4制御性T細胞のアポトーシスを抑制する(Low-close interleukin-2 induces BCL2 expression and resistance to apoptosis in CD4 regulatory T Cells). 札幌医学雑誌. 2018. 87. 1-6. 49-61
-
Hiroyuki Ohnuma, Masahiro Hirakawa, Shohei Kikuchi, Yasushi Sato, Koichi Takada, Koji Miyanishi, Junji Kato. A multidisciplinary treatment approach using docetaxel, nedaplatin, and 5-FU for advanced esophageal cancer. ANNALS OF ONCOLOGY. 2017. 28
-
Y. Arihara, K. Takada, Y. Kawano, N. Hayasaka, H. Nakamura, S. Kikuchi, Y. Kamihara, K. Murase, H. Ikeda, S. Iyama, et al. P53-RESTORING SMALL MOLECULE CP-31398 INDUCES APOPTOSIS VIA INDUCTION OF REACTIVE OXIDATIVE SPECIES IN HUMAN MULTIPLE MYELOMA. HAEMATOLOGICA. 2017. 102. 498-498
more...
Work history (3):
- 2016/11 - 現在 札幌医科大学 医学部 腫瘍内科学講座
- 2011/04 - 2016/10 Sapporo Medical University School of Medicine
- 2009/03 - 2011/03 Harvard University Dana-Farber Cancer Institute
Awards (7):
Return to Previous Page